-
4441
WNT11 Promotes immune evasion and resistance to Anti-PD-1 therapy in liver metastasis
Published 2025-02-01Get full text
Article -
4442
Effects of <i>Bifidobacterium longum longum</i> 35624® on the Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: Results of the Multicenter Observational Progr...
Published 2024-12-01“…Eligible patients were diagnosed with IBS according to the Rome IV Criteria and clinical guidelines of the Russian Association of Gastroenterology and the Association of Colorectal Surgeons of Russia. …”
Get full text
Article -
4443
A Review on Complications and Management of Aluminium Phosphide (Rice Pill) and Zinc Phosphide Poisoning
Published 2024-09-01Get full text
Article -
4444
CHST1 as a prognostic-related biomarker in gastric cancer correlating with immune infiltration
Published 2025-02-01Get full text
Article -
4445
Significance of immune factors in Crohn's disease development
Published 2015-07-01Get full text
Article -
4446
Case Report of Gastrointestinal Bleeding in an Adult with Chronic Visceral Acid Sphingomyelinase Deficiency
Published 2019-01-01Get full text
Article -
4447
-
4448
-
4449
-
4450
-
4451
-
4452
Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes
Published 2020-01-01Get full text
Article -
4453
Diagnostic and prognostic values of tsRNAs in lung cancer: a meta-analysis
Published 2025-01-01Get full text
Article -
4454
Evaluation of the Frequency of HLA-DQ2/DQ8 Genes Among Patients with Celiac Disease and Those on a Gluten-Free Diet
Published 2025-01-01“…All subjects underwent a genetic analysis assessing the presence of histocompatibility antigens HLA-DQ2.2, -DQ2.5, and -DQ8, along with the assessment of alleles encoding the α and β subunits of the antigens, according to European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) guidelines from 2020, using the EUROarray technique at EUROIMMUNE<sup>®</sup>. …”
Get full text
Article -
4455
-
4456
Protocol for a first-in-human feasibility study of T regulatory cells (TR004) for inflammatory bowel disease using (ex vivo) Treg expansion (TRIBUTE)
Published 2025-01-01“…This study will explore the preliminary safety and tolerability of a single dose of Treg immunotherapy and will inform the design of a subsequent larger trial.Methods and analysis Four patients will be recruited from gastroenterology clinics at Guy’s and St Thomas’ NHS Foundation Trust. …”
Get full text
Article -
4457
-
4458
-
4459
-
4460